Disposition of 1220 shares by Harry Chapman of US Physicalrapy at 94.75 subject to Rule 16b-3
USPH Stock | USD 88.18 0.30 0.34% |
Under 53% of US Physicalrapy's investor base is interested to short. The analysis of overall sentiment of trading US Physicalrapy stock suggests that many investors are impartial at this time. US Physicalrapy's investing sentiment shows overall attitude of investors towards US Physicalrapy.
USPH |
Filed transaction by US Physicalrapy Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
US Physicalrapy Fundamental Analysis
We analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
US Physicalrapy is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
US Physicalrapy Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with US Physicalrapy stock to make a market-neutral strategy. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics with similar companies.
Peers
US Physicalrapy Related Equities
AGL | Agilon Health | 8.85 | ||||
ACHC | Acadia Healthcare | 8.71 | ||||
HCSG | Healthcare Services | 2.62 | ||||
DVA | DaVita HealthCare | 2.00 | ||||
EHAB | Enhabit | 1.55 | ||||
INNV | InnovAge Holding | 1.02 | ||||
SGRY | Surgery Partners | 0.57 | ||||
PNTG | Pennant | 0.30 | ||||
ADUS | Addus HomeCare | 0.27 | ||||
ENSG | Ensign | 0.28 | ||||
HCA | HCA Holdings | 0.35 | ||||
UHS | Universal Health | 0.43 | ||||
EHC | Encompass Health | 0.73 | ||||
THC | Tenet Healthcare | 2.05 | ||||
SEM | Select Medical | 2.08 |
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Transaction History View history of all your transactions and understand their impact on performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |